L&K Biomed Ltd. (KOSDAQ:156100)

Market Cap	304.44B +115.1%
Revenue (ttm)	40.33B +21.5%
Net Income	5.84B
EPS	265.47
Shares Out	22.17M
PE Ratio	51.72
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	295,654
Average Volume	381,173
Open	14,230
Previous Close	14,640
Day's Range	13,510 - 14,620
52-Week Range	5,570 - 16,400
Beta	0.85
RSI	46.81
Earnings Date	Mar 12, 2026

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2008
• Employees: 101
• Stock Exchange: KOSDAQ
• Ticker Symbol: 156100